AU Stock MarketDetailed Quotes

1AD AdAlta Ltd

Watchlist
  • 0.005
  • -0.001-16.67%
20min DelayNot Open Apr 28 10:00 AET
3.22MMarket Cap-0.45P/E (Static)

About AdAlta Ltd Company

AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation protein and cell-based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.

Company Profile

Symbol1AD
Company NameAdAlta Ltd
Founded2006
MarketASX
Employees9
Fiscal Year Ends06-30
AddressScience Drive La Trobe Institute for Molecular Science, Room 204, LIMS2
CityBundoora
CountryAustralia
Zip Code3086
Phone+61 394795159
Share RegistryAUTOMIC REGISTRY SERVICES Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000 02 9698 5414

Company Executives

  • Name
  • Position
  • Salary
  • Timothy Oldham
  • Managing Director,Chief Executive Officer
  • --
  • Paul MacLeman
  • Non-Executive Chairman,Non-Executive Director
  • --
  • Robert Peach
  • Non-Executive Director
  • --
  • David Fuller
  • Non-Executive Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More